Cenovus to hold second-quarter conference call and webcast
Get Alerts CVE Hot Sheet
Join SI Premium – FREE
CALGARY, Alberta, July 20, 2023 (GLOBE NEWSWIRE) -- Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) will release its second-quarter 2023 results on Thursday, July 27. The news release will provide consolidated second-quarter operating and financial information. The company’s financial statements will be available on Cenovus’s website, cenovus.com.
Conference call: 9 a.m. MT (11 a.m. ET)
To join the conference call without operator assistance, please register here approximately 5 minutes in advance to receive an automated call-back when the session begins.
Alternatively, you can dial 888-664-6383 (toll-free in North America) or 416-764-8650 to reach an operator who will place you in the call.
Access the live audio webcast here.
Cenovus Energy Inc.
Cenovus Energy Inc. is an integrated energy company with oil and natural gas production operations in Canada and the Asia Pacific region, and upgrading, refining and marketing operations in Canada and the United States. The company is focused on managing its assets in a safe, innovative and cost-efficient manner, integrating environmental, social and governance considerations into its business plans. Cenovus common shares and warrants are listed on the Toronto and New York stock exchanges, and the company’s preferred shares are listed on the Toronto Stock Exchange. For more information, visit cenovus.com.
Find Cenovus on Facebook, Twitter, LinkedIn, YouTube and Instagram.
Cenovus contacts:
| Investors | Media |
| Investor Relations general line403-766-7711 | Media Relations general line403-766-7751 |
Source: Cenovus Energy Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Atlanta Technology Leaders to Gather Tomorrow for HMG Strategy’s 17th Annual C-Level Technology Leadership Summit on AI Governance, Agentic AI and Cybersecurity Resilience
- Steelworkers welcome tariff pause, call on the government to hold the line for Canadian workers and jobs
- BioMedNewsBreaks — Silo Pharma Inc. (NASDAQ: SILO) Receives Canadian Patent Allowance for Lead Asset SPC-15
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share